Long-circulating XTEN864-annexin A5 fusion protein for phosphatidylserine-related therapeutic applications | SpringerLink
Production and biophysical characterization of an exenatide-XTEN... | Download Scientific Diagram
Extension of in vivo half-life of biologically active molecules by XTEN protein polymers - ScienceDirect
Addgene: pCAG-NLS(SV40)x2-rAPOBEC1-gs-XTEN-gs-hdLbCas12a(D832A)-gs-UGI-NLS(SV40)(LbBE1.4) (RTW1293) Sequences
Extension of in vivo half-life of biologically active molecules by XTEN protein polymers - ScienceDirect
Evaluation of hyPE2 linker variants. a Detailed information about the... | Download Scientific Diagram
Precision-activated T-cell engagers targeting HER2 or EGFR and CD3 mitigate on-target, off-tumor toxicity for immunotherapy in solid tumors | Nature Cancer
Multivalent Antiviral XTEN–Peptide Conjugates with Long in Vivo Half-Life and Enhanced Solubility | Bioconjugate Chemistry
XTEN-Annexin A5: XTEN Allows Complete Expression of Long-Circulating Protein-Based Imaging Probes as Recombinant Alternative to
Extension of in vivo half-life of biologically active molecules by XTEN protein polymers - ScienceDirect
Targeted Base Editing Systems Are Available for Plants: Trends in Plant Science
WO2017024060A1 - Factor ix fusion proteins and methods of making and using same - Google Patents
Addgene: pCAG-rAPOBEC1-gs-XTEN-gs-hdenAsCas12a(E174R/S542R/K548R/D908A)-NLS(nucleoplasmin)-gs-UGI-NLS(SV40)(enAsBE1.1) (RTW1352)
Introduction to XTEN v1
Dually Reactive Long Recombinant Linkers for Bioconjugations as an Alternative to PEG | ACS Omega
XTENylation Service - Profacgen
Addgene: pCAG_NLS-Cas9-XTEN-Ec73RT-NLS_pA_pCMV_BFP_pA
Drug Discovery News on Twitter: "#Amunix closes $117M #SeriesB #financing to advance its masked #protease-activated #Tcell engagers (#XPATs) & #cytokines (#XPACs) Look to advance AMX-818 XPAT vs #HER2-expressing solid #tumors to clinic
Multivalent Antiviral XTEN–Peptide Conjugates with Long in Vivo Half-Life and Enhanced Solubility
Addgene: pCAG_NLS-Cas9-XTEN-Ec73RT-NLS_pA_pCMV_BFP_pA
Extension of in vivo half-life of biologically active molecules by XTEN protein polymers - ScienceDirect
Expanding the genome-targeting scope and the site selectivity of high-precision base editors | Nature Communications
Versartis - Preparing To Get A Lot Bigger, Very Soon (NASDAQ:VSAR-OLD) | Seeking Alpha
Team:NUS Singapore-Sci/molecular dynamics - 2018.igem.org
